Free shipping on all orders over $ 500

9-Aminocamptothecin

Cat. No. M25388
9-Aminocamptothecin Structure
Synonym:

9-amino-CPT; 9-amino-20(S)-camptothecin

Size Price Availability Quantity
5mg USD 110  USD110 In stock
10mg USD 160  USD160 In stock
25mg USD 295  USD295 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

9-Aminocamptothecin (9-amino-CPT) is a topoisomerase I inhibitor with potent anticancer activity. 9-Aminocamptothecin inhibits PC-3, PC-3M, DU145, and LNCaP cells with IC50 values of 34.1, 10, 6.5, and 8.9 nM, respectively after 96 h exposure.

9-Aminocamptothecin (9-amino-CPT) inhibits tumor growth at the lowest oral dose (0.35 mg/kg/day), whereas higher oral doses (0.75 and 1 mg/kg/day) and s.c. administration (4 mg/kg/week) causes tumor regression. 9-Aminocamptothecin (9-amino-CPT) is well tolerated at all doses, with no toxic death or weight loss of more than 10% observed in any group. 9-Aminocamptothecin (9-amino-CPT) induces complete remissions in 55 % of SCID mice engrafted with human myeloid leukemia.

Chemical Information
Molecular Weight 363.37
Formula C20H17N3O4
CAS Number 91421-43-1
Solubility (25°C) DMSO 3 mg/mL (Need ultrasonic)
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Hedy L Kindler, et al. Invest New Drugs. 9-Aminocamptothecin (9-AC) given as a 120-hour continuous infusion in patients with advanced adenocarcinomas of the stomach and gastroesophageal junction: A phase II trial of the University of Chicago phase II consortium

[2] C H Takimoto, et al. Ann N Y Acad Sci. The clinical development of 9-aminocamptothecin

[3] F Muggia, et al. Ann N Y Acad Sci. Intraperitoneal topoisomerase-I inhibitors. Preliminary findings with 9-aminocamptothecin

[4] M Potmesil, et al. Ann N Y Acad Sci. 9-Aminocamptothecin and beyond. Preclinical and clinical studies

[5] J P Lamond, et al. Int J Radiat Oncol Biol Phys. Radiation lethality enhancement with 9-aminocamptothecin: comparison to other topoisomerase I inhibitors

Related Topoisomerase Products
ICRF-193

ICRF-193 is an TopoII inhibitor.

Topoisomerase II inhibitor 15

Topoisomerase II inhibitor 15 is a Topoisomerase II inhibitor.

Topoisomerase II inhibitor 13

Topoisomerase II inhibitor 13 is a topoisomerase II (Topo II) inhibitor.

ICRF-196

ICRF-196 is an racemic mixture of the (S,S)- and (R,R)-isomers of ICRF-193.

Cholesteryl hemisuccinate

Cholesteryl hemisuccinate is a with hepatoprotective an anticancer activity.

  Catalog
Abmole Inhibitor Catalog




Keywords: 9-Aminocamptothecin, 9-amino-CPT; 9-amino-20(S)-camptothecin supplier, Topoisomerase, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.